Weight of mice in studies of combination therapy with anti-PD-L1 antibody. 129S4 mice with ADS-12 tumors were treated with intratumoral buffer or mouse-ADAPT-001 on days 0, 4, and 8 and intraperitoneal buffer or anti-PD-L1 antibody on days 1, 5, 9, and 13. Mean ± standard deviation of weight normalized to pre-treatment baseline is plotted for each group. n=10 mice in each group.